These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7963116)

  • 21. Thoratec implantable ventricular assist device: the Papworth experience.
    Berman M; Parameshwar J; Jenkins DP; Dhital K; Lewis C; Dempster K; Lincoln P; Sudarshan C; Large SR; Dunning J; Tsui SS
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):466-73. PubMed ID: 19833355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmias after left ventricular assist device implantation: Incidence and management.
    Kadado AJ; Akar JG; Hummel JP
    Trends Cardiovasc Med; 2018 Jan; 28(1):41-50. PubMed ID: 28734595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.
    El-Banayosy A; Arusoglu L; Kizner L; Tenderich G; Minami K; Inoue K; Körfer R
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):581-7. PubMed ID: 10694620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular arrhythmias during left ventricular assist device support.
    Bedi M; Kormos R; Winowich S; McNamara DM; Mathier MA; Murali S
    Am J Cardiol; 2007 Apr; 99(8):1151-3. PubMed ID: 17437746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmias in children with ventricular assist devices.
    Kyle WB; Decker J; Macicek SL; Valdes SO; Morales D; Hong B; Price JF; Dreyer WJ; Denfield SW; Kim JJ
    Cardiol Young; 2015 Feb; 25(2):255-60. PubMed ID: 25647466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic performance and inflammatory response during the use of VAD-InCor as a bridge to transplant.
    Galantier J; Moreira LF; Benício A; Leirner AA; Cestari I; Bocchi EA; Bacal F; Stolf NA
    Arq Bras Cardiol; 2008 Nov; 91(5):327-34. PubMed ID: 19142378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.
    Vetter HO; Kaulbach HG; Schmitz C; Forst A; Uberfuhr P; Kreuzer E; Pfeiffer M; Brenner P; Dewald O; Reichart B
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):74-80. PubMed ID: 7815810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.
    Lü F; Eckman PM; Liao KK; Apostolidou I; John R; Chen T; Das GS; Francis GS; Lei H; Trohman RG; Benditt DG
    Int J Cardiol; 2013 Oct; 168(4):3859-65. PubMed ID: 23863501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure.
    Harding JD; Piacentino V; Rothman S; Chambers S; Jessup M; Margulies KB
    J Card Fail; 2005 Apr; 11(3):227-32. PubMed ID: 15812752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical storm in the early phase of HeartMate
    Corre J; Picard F; Garcia R; Zemmoura A; Derval N; Denis A; Romen A; Nubret K; Jais P; Haissaguerre M; Dos Santos P; Barandon L; Sacher F
    Arch Cardiovasc Dis; 2018 May; 111(5):332-339. PubMed ID: 29217463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.
    Garan AR; Levin AP; Topkara V; Thomas SS; Yuzefpolskaya M; Colombo PC; Takeda K; Takayama H; Naka Y; Whang W; Jorde UP; Uriel N
    J Heart Lung Transplant; 2015 Dec; 34(12):1611-6. PubMed ID: 26212658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation.
    Patil NP; Mohite PN; Sabashnikov A; Dhar D; Weymann A; Zeriouh M; Hards R; Hedger M; De Robertis F; Bahrami T; Amrani M; Rahman-Haley S; Banner NR; Popov AF; Simon AR
    J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1651-8. PubMed ID: 26318358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure.
    Mancini DM; Beniaminovitz A; Levin H; Catanese K; Flannery M; DiTullio M; Savin S; Cordisco ME; Rose E; Oz M
    Circulation; 1998 Dec; 98(22):2383-9. PubMed ID: 9832482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
    Schenk S; McCarthy PM; Blackstone EH; Feng J; Starling RC; Navia JL; Zhou L; Hoercher KJ; Smedira NG; Fukamachi K
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):447-54. PubMed ID: 16434277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Native heart complications after heterotopic heart transplantation: insight into the potential risk of left ventricular assist device.
    Tagusari O; Kormos RL; Kawai A; Yamazaki K; Pham SM; Hattler BG; Murali S; Griffith BP
    J Heart Lung Transplant; 1999 Nov; 18(11):1111-9. PubMed ID: 10598735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.